{"nct_id":"NCT03031938","title":"Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2017-11-03","start_date_type":"ACTUAL","primary_completion_date":"2020-06-04","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}